Bay Colony Advisory Group, Inc D Regenxbio Inc. Transaction History

Bay Colony Advisory Group, Inc D

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Apr 17, 2020	SELL	$21.5 - $54.2 $116,100 - $292,680	-5,400 Closed	0 $0
Q4 2019 Jan 28, 2020	BUY	$34.54 - $44.87 $186,516 - $242,298	5,400 New	5,400 $253,000
Q4 2019 Jan 28, 2020	SELL	$34.54 - $44.87 $250,415 - $325,307	-7,250 Closed	0 $0
Q3 2019 Oct 25, 2019	BUY	$31.84 - $50.88 $50,944 - $81,408	1,600 Added 28.32%	7,250 $258,000
Q2 2019 Jul 17, 2019	BUY	$42.0 - $59.29 $237,300 - $334,988	5,650 New	5,650 $290,000
Q3 2018 Nov 05, 2018	SELL	$65.0 - $82.15 $630,500 - $796,855	-9,700 Closed	0 $0
Q2 2018 Aug 09, 2018	BUY	$27.2 - $74.35 $263,840 - $721,195	9,700 New	9,700 $696,000

196

43M

104K

478K

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $340M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

Get notified when there are updates to the investment portfolio of Bay Colony Advisory Group, Inc D, based on Form 13F filings with the SEC.

Stay updated on Bay Colony Advisory Group, Inc D with notifications on news.